A psychiatric medication system in the form of a pill with a built-in digital tracking device gained approval from the US Food and Drug Administration on Monday. 
Abilify MyCite, a form of aripiprazole and a first-of-its-kind product, has an embedded ingestible sensor that records when the medication is taken. Made by Japan-based Otsuka Pharmaceutical Co., the medication system is intended to treat schizophrenia, bipolar I disorder and depression in adults. Abilify without sensor technology was first approved to treat schizophrenia in 2002.
Schizophrenia, a psychotic disorder, includes symptoms of delusions and hallucinations. Bipolar patients may experience alternating episodes of mania and depression, a persistent sadness.
Related
Peter Sobat
Peter Sobat is a Los Angeles based creative entrepreneur who built his career in television, music videos, and documentaries. He helped develop the hit series Bridezillas, has directing and producing credits on MythBusters, Pimp My Ride, and Trading Spaces, and, as executive producer of Cypress Hill’s BReal TV, created The SmokeBox, which has generated billions of views. His award-winning music videos and documentaries have been shot on six continents for networks including CBS, MTV, ABC, ESPN, FOX, and Discovery, and for artists such as Snoop Dogg, Wiz Khalifa, Cypress Hill, Bone Thugs-N-Harmony, YG, Nipsey Hussle, and Wu-Tang Clan.
He founded BlurredCulture.com, a culture site that has reached millions of views, and The Bakerie, a cannabis brand that grew to operations in multiple states. Today he runs the Department of Peculiar Ideas (TheDopi.com), a boutique agency creating branding and campaigns for adidas, Nike, Ford, Ram, Japan Airlines, LAFC, Cookies, and High Times.